Allergy Therapeutics has an EPS of $-0.0761. In 2022, the company made an earnings per share (EPS) of $-0.0214. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.0761 | 255.61% |
2022 | -$0.0214 | -597.67% |
2021 | $0.0043 | -59.05% |
2020 | $0.0105 | - |